Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Therapeutic Drug Monitoring
|
June 13, 2000
Goal-oriented, model-based drug regimens: setting individualized goals for each patient
R Jelliffe
International Journal of Clinical Pharmacology and Therapeutics
|
March 31, 2004
Individual dose optimization: why and how
R Jelliffe
Computers in Biology and Medicine
|
February 15, 2001
Creating discrete joint densities from continuous ones: the moment matching-maximum entropy approach
M Milman, F Jiang, R Jelliffe
Clinical Pharmacokinetics
|
May 1, 2001
Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials
A Aminimanizani, P Beringer, R Jelliffe
Therapeutic Drug Monitoring
|
June 13, 2000
Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods
R Jelliffe, A Schumitzky, M Van Guilder
Therapeutic Drug Monitoring
|
June 13, 2000
Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens
R Jelliffe, D Bayard, M Milman, et al.
Therapeutic Drug Monitoring
|
April 1, 1994
Prediction of future serum concentrations with Bayesian fitted pharmacokinetic models: results with data collected by nurses versus trained pharmacy residents
B Charpiat, V Breant, C Pivot-Dumarest, et al.
Therapeutic Drug Monitoring
|
June 13, 2000
Diurnal changes in the pharmacokinetic behavior of amikacin
N Bleyzac, B Allard-Latour, A Laffont, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2015
Population modeling and simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of isoniazid in lungs
L Lalande, L Bourguignon, S Bihari, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1980
Effect of an oral dose of 25-hydroxyvitamin D3 on its blood levels in patients with the nephrotic syndrome
B Haldimann, M Healy, R Jelliffe, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Therapeutic Drug Monitoring
|
June 13, 2000
Goal-oriented, model-based drug regimens: setting individualized goals for each patient
R Jelliffe
International Journal of Clinical Pharmacology and Therapeutics
|
March 31, 2004
Individual dose optimization: why and how
R Jelliffe
Computers in Biology and Medicine
|
February 15, 2001
Creating discrete joint densities from continuous ones: the moment matching-maximum entropy approach
M Milman, F Jiang, R Jelliffe
Clinical Pharmacokinetics
|
May 1, 2001
Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials
A Aminimanizani, P Beringer, R Jelliffe
Therapeutic Drug Monitoring
|
June 13, 2000
Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods
R Jelliffe, A Schumitzky, M Van Guilder
Therapeutic Drug Monitoring
|
June 13, 2000
Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens
R Jelliffe, D Bayard, M Milman, et al.
Therapeutic Drug Monitoring
|
April 1, 1994
Prediction of future serum concentrations with Bayesian fitted pharmacokinetic models: results with data collected by nurses versus trained pharmacy residents
B Charpiat, V Breant, C Pivot-Dumarest, et al.
Therapeutic Drug Monitoring
|
June 13, 2000
Diurnal changes in the pharmacokinetic behavior of amikacin
N Bleyzac, B Allard-Latour, A Laffont, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2015
Population modeling and simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of isoniazid in lungs
L Lalande, L Bourguignon, S Bihari, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1980
Effect of an oral dose of 25-hydroxyvitamin D3 on its blood levels in patients with the nephrotic syndrome
B Haldimann, M Healy, R Jelliffe, et al.
Page
of 2